Navigation Links
Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc.
Date:4/25/2013

BALA CYNWYD, Pa., April 25, 2013 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of PROLOR Biotech, Inc. ("PROLOR" or the "Company") (NYSE- PBTH) relating to the proposed acquisition by OPKO Health, Inc. ("OPKO").

Under the terms of the transaction, PROLOR shareholders will receive only 0.9951 shares of OPKO stock for each share of PROLOR stock they own. The transaction values PROLOR stock at approximately $7.025 per share. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of PROLOR for not acting in the Company's shareholders' best interests in connection with the sale process. The transaction may undervalue the Company as an analyst has set a $12.00 per share price target on PROLOR stock. In addition, it has been reported that Deerpath Capital has indicated that the Company is worth more than $10.00 per share.

If you own shares of PROLOR stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions.  You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com visiting http://brodsky-smith.com/571-pbth-prolor-biotech-inc.html, by calling toll free 877-LEGAL-90.

Attorney advertising. Prior results do not guarantee a similar outcome.


'/>"/>
SOURCE Brodsky & Smith, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
2. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
5. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
6. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
7. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
8. Codexis Names Wes Bolsen VP and Chief Marketing Officer
9. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
10. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
11. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
Breaking Biology News(10 mins):